https://wikimd.org/index.php?action=history&feed=atom&title=Methocinnamox 2026-04-25T06:01:52Z Revision history for this page on the wiki MediaWiki 1.44.2 https://wikimd.org/index.php?title=Methocinnamox&diff=6336242&oldid=prev 2025-02-20T01:45:30Z

<p>CSV import</p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 01:45, 20 February 2025</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l22">Line 22:</td> <td colspan="2" class="diff-lineno">Line 22:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>[[Category:Neuropharmacology]]</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>[[Category:Neuropharmacology]]</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{Pharma-stub}}</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{Pharma-stub}}</div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">&lt;gallery&gt;</ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">File:Methocinnamox.svg|Methocinnamox</ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">&lt;/gallery&gt;</ins></div></td></tr> </table>

Prab https://wikimd.org/index.php?title=Methocinnamox&diff=5331143&oldid=prev 2024-02-29T04:46:36Z

<p>CSV import</p> <p><b>New page</b></p><div>&#039;&#039;&#039;Methocinnamox&#039;&#039;&#039; is a potent [[opioid]] antagonist and partial agonist. It is derived from [[naltrexone]] and is used in the field of [[neuropharmacology]] to study the opioid system. Methocinnamox has a high affinity for the [[mu opioid receptor]], but also binds to the [[kappa opioid receptor]] and the [[delta opioid receptor]].<br /> <br /> ==Chemistry==<br /> Methocinnamox is a derivative of naltrexone, which is itself a derivative of [[oxymorphone]]. The chemical structure of methocinnamox includes a methoxy group, which is responsible for its increased potency compared to naltrexone.<br /> <br /> ==Pharmacology==<br /> Methocinnamox acts as an antagonist at the mu opioid receptor, meaning it blocks the effects of opioids at this receptor. However, it also has partial agonist activity, meaning it can activate the receptor to a lesser extent than a full agonist. This dual action makes methocinnamox a unique tool in the study of the opioid system.<br /> <br /> ==Uses==<br /> In neuropharmacology, methocinnamox is used to study the opioid system. It can be used to block the effects of opioids, or to mimic their effects to a lesser extent. This can help researchers understand how opioids work and how they can be used in medicine.<br /> <br /> ==Safety==<br /> As an opioid antagonist, methocinnamox can precipitate withdrawal symptoms in individuals who are dependent on opioids. Therefore, it should be used with caution in this population.<br /> <br /> ==See also==<br /> * [[Naltrexone]]<br /> * [[Opioid receptor]]<br /> * [[Neuropharmacology]]<br /> <br /> [[Category:Opioids]]<br /> [[Category:Pharmacology]]<br /> [[Category:Neuropharmacology]]<br /> {{Pharma-stub}}</div>

Prab